---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006722"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2024-02-14T23:59:59+00:00"
generated_at: "2026-06-06T01:58:06.458981+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elite Pharma Q3 revenue up 68% to $15.5M; operating profit up 80% to $3.5M

## Summary
- Revenue $15.5M for Q3 FY2024 ended Dec 31, 2023, +68% YoY from $9.2M.
- Operating profit $3.5M, +80% YoY from $1.9M.
- Growth attributable to sales of Elite Laboratories label products launched during FY2024.
- Company to hold conference call Feb 15, 2024 at 11:30 AM EST.

## SEC filing metadata
- accession: 0001493152-24-006722
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2024-02-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315224006722/0001493152-24-006722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315224006722/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006722
- JSON: https://secwatch.observer/filing/0001493152-24-006722.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006722.txt

## Key facts
- Earnings Releases
  ELITE PHARMACEUTICALS INC /NV/ reported third quarter of fiscal year 2024 ended December 31, 2023 results: revenue $15.5 million.
  - Period: third quarter of fiscal year 2024 ended December 31, 2023
  - Revenue: $15.5 million
  - Result: reported results
  source text: Consolidated revenues for the three-month period ended December 31, 2023, were $15.5 million, an increase of $6.3 million or 68% as compared to the comparable period of the prior fiscal year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053369/000149315224006722/0001493152-24-006722-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.